CNOT1 and nonpapillary renal cell carcinoma: Likewise, ccRCC patients with high CNOT1 expression had better OS (P< 0.0001) and PFS (P= 0.00018) than those with low expression (Figure 3C, 3D), and patients in the high SIN3A expression group also had better OS (P= 0.00081) and PFS (P= 0.00015) outcomes than those in the low expression group (Figure 3E, 3F).